Instalab

Tissue Transglutaminase IgA Can Diagnose Celiac Disease With 98% Accuracy

Tissue transglutaminase IgA (tTG-IgA) is the single best blood test for catching celiac disease. With sensitivity as high as 98% and specificity up to 98% in untreated patients, it rarely gets the diagnosis wrong. But here's the catch most people don't hear about: once you start a gluten-free diet and your numbers drop, a normal tTG-IgA result has less than 50% sensitivity for detecting ongoing intestinal damage. The test that's brilliant at finding celiac disease is surprisingly poor at confirming you've actually healed from it.

That gap matters. Understanding what tTG-IgA can and can't tell you at each stage changes how you should interpret your lab results, what follow-up to push for, and when a number on a page doesn't tell the whole story.

What tTG-IgA Actually Measures

When someone with celiac disease eats gluten, their immune system mounts an autoimmune attack on the lining of the small intestine. That attack produces specific autoantibodies targeting an enzyme called tissue transglutaminase. The tTG-IgA test measures the level of those autoantibodies in your blood.

Think of it as a smoke detector for celiac-related intestinal inflammation. When the fire is burning (active, untreated celiac disease), the alarm is almost always going off. When you remove the fuel (gluten), the alarm gradually quiets down. But a silent alarm doesn't guarantee the fire is fully out.

Why It's the Go-To Screening Test

For initial diagnosis in someone who hasn't gone gluten-free yet, tTG-IgA is hard to beat. The numbers across large studies are consistently strong:

  • Sensitivity: 92–98% (it catches nearly everyone who has celiac disease)
  • Specificity: 95–98% (it rarely flags people who don't have it)
  • Positive predictive value: 83–98% for any elevated result in large pediatric studies

Doctors typically order it alongside a total IgA level. That pairing matters because a small percentage of people are IgA-deficient, which means their bodies don't produce enough IgA antibodies to trigger a positive result, even if they have celiac disease. For those individuals, alternative tests like tTG-IgG or DGP-IgG (deamidated gliadin peptide IgG) are used instead.

The 10x Threshold That Can Replace a Biopsy

Not all positive results carry the same weight. How high your tTG-IgA climbs above the upper limit of normal (ULN) dramatically changes what your doctor can conclude.

tTG-IgA LevelWhat It Means Diagnostically
Elevated (any amount above ULN)PPV of 83–98%; biopsy typically still recommended to confirm
≥5× ULNPPV around 85%; strong signal, but not definitive on its own
≥10× ULNPPV ≥95%, approaching ~100% specificity in adults with moderate-to-high pre-test probability

That ≥10× ULN threshold is the basis for "no-biopsy" diagnosis, a strategy now used especially in children and increasingly considered in adults. When tTG-IgA is that high and the clinical picture fits, some guidelines allow a celiac diagnosis without an endoscopy. This is a significant shift from the traditional requirement of intestinal biopsy for every patient.

For adults, this no-biopsy path works best when pre-test probability is already moderate to high, meaning symptoms, family history, or associated conditions already point toward celiac disease. A sky-high tTG-IgA in that context is about as close to a sure thing as serologic testing gets.

Special Situations: Young Children and IgA Deficiency

The test performs well across age groups, but two scenarios require extra attention.

  • Children under 2 years: tTG-IgA remains the best single test even in very young children, but adding DGP-IgG to the panel helps avoid missed diagnoses. Young immune systems are still maturing, and relying on tTG-IgA alone may leave gaps.
  • IgA deficiency: If your total IgA is low, the standard tTG-IgA test is essentially blind. Your body isn't making enough of the antibody class being measured. In this case, tTG-IgG with or without DGP-IgG should be used instead. This is why checking total IgA alongside tTG-IgA at the initial screen isn't just a formality.

The Monitoring Trap: When Normal Numbers Mislead

Once you're on a gluten-free diet, tTG-IgA typically falls and often normalizes within one to two years, though the timeline varies by person and by the specific lab assay used. Watching that number trend downward is genuinely useful. A persistently elevated tTG-IgA on a gluten-free diet suggests ongoing gluten exposure, whether intentional or not.

But the reverse isn't true, and this is where people get tripped up. A normal tTG-IgA while on a gluten-free diet does not reliably mean your intestinal lining has healed. Meta-analysis data shows the test has less than 50% sensitivity for detecting persistent villous atrophy (ongoing damage to the finger-like projections in your small intestine) in treated patients. Specificity stays high, so a positive result still means something. But a negative result? It's not the all-clear many people assume it is.

This has real implications. If confirming mucosal healing matters for your care, whether because of persistent symptoms, nutritional deficiencies, or risk stratification, tTG-IgA alone cannot answer that question. Biopsy remains the more definitive tool for assessing whether the intestinal lining has actually recovered.

Higher Numbers, Worse Damage

There is a meaningful correlation between how high your tTG-IgA (or tTG-IgG) titer is and the severity of intestinal damage seen on biopsy. Higher titers tend to correspond to more advanced Marsh grades, the histologic scoring system pathologists use to classify the degree of injury in duodenal tissue.

This connection also extends beyond the gut. IgA-tTG autoantibodies can deposit in other tissues, including the kidney, liver, and brain. However, the research notes that such deposits are not specific to celiac disease alone, so their clinical significance in a given patient requires careful interpretation.

Making Sense of Your Results

Your tTG-IgA number means different things depending on where you are in the process.

Your SituationWhat tTG-IgA Tells YouWhat It Doesn't Tell You
Not yet diagnosed, eating glutenA positive result is a strong signal for celiac disease; ≥10× ULN may be diagnostic on its ownIt can miss celiac disease in IgA-deficient individuals
Newly diagnosed, starting gluten-free dietProvides a baseline to track your response over timeA single value doesn't predict how quickly you'll heal
On a gluten-free diet, levels droppingSuggests reduced autoimmune activity; the diet is likely workingA normal result does not confirm your intestine has healed
On a gluten-free diet, levels not droppingLikely ongoing gluten exposure or non-adherenceIt doesn't pinpoint the source of exposure

The clearest takeaway: trust tTG-IgA most at the front end, when you're being evaluated for celiac disease and still eating gluten. Trust it least as a sole measure of healing after you've changed your diet. It's a powerful diagnostic tool with a genuine blind spot in the monitoring phase, and knowing where that blind spot sits puts you in a much better position to advocate for the right follow-up.

References

61 sources
  1. Alessio, MG, Tonutti, E, Brusca, I, Radice, a, Licini, L, Sonzogni, a, Florena, a, Schiaffino, E, Marus, W, Sulfaro, S, Villalta, DJournal of Pediatric Gastroenterology and Nutrition2012
  2. Dahlbom, I, Korponay-szabó, IR, Kovács, JB, Szalai, Z, Mäki, M, Hansson, TJournal of Pediatric Gastroenterology and Nutrition2010
  3. Donat, E, Roca, M, Castillejo, G, Sánchez-valverde, F, García-burriel, JI, Martínez-ojinaga, E, Eizaguirre, FJ, Barrio, J, Cilleruelo, ML, Pérez-solís, D, Ochoa-sangrador, C, Vecino-lópez, R, Miranda-cid, MDC, García-calatayud, S, Torres-peral, R, Juste, M, Armas, H, Barros-garcía, P, Leis, R, Solaguren, R, Salazar, JC, García-romero, R, Ortigosa, L, Peña-quintana, L, Urruzuno, P, Codoñer-franch, P, Garcia-casales, Z, Masiques, ML, Galicia-poblet, G, Crehuá-gaudiza, E, Balmaseda, E, Rubio-santiago, J, Polanco-allué, I, Román-riechmann, E, Ribes-koninckx, CJournal of Pediatric Gastroenterology and Nutrition2022
  4. Packova, B, Kovalcikova, P, Pavlovsky, Z, Bartusek, D, Prokesova, J, Dolina, J, Kroupa, RWorld Journal of Gastroenterology2020
  5. Vivas, S, Ruiz De Morales, JG, Riestra, S, Arias, L, Fuentes, D, Alvarez, N, Calleja, S, Hernando, M, Herrero, B, Casqueiro, J, Rodrigo, LWorld Journal of Gastroenterology2009
Free · 2 min

Which tests could save your life?

With over 1,000 diagnostic tests out there, most people have no idea which ones actually matter. Our physicians do.

1Answer a few quick questions
2See your personalized testing plan
3We handle scheduling to results. No referral needed.
72%of members uncover a new health risk within their first month
No signup required
Free · 2 min

Which tests could save your life?

With over 1,000 diagnostic tests out there, most people have no idea which ones actually matter. Our physicians do.

1Answer a few quick questions
2See your personalized testing plan
3We handle scheduling to results. No referral needed.
72%of members uncover a new health risk within their first month
No signup required